Electronic health records from 77 health care organizations in the US were evaluated for a risk for endocarditis among patients with opioid use disorder or cocaine use disorder on the basis of contracting COVID-19.
Your search for major depressive disorder returned 148 results
Click on a filter below to refine your search. Remove a filter to broaden your search.
Researchers sought to evaluate the efficacy and safety of galcanezumab in patients with migraine in Japan.
American College of Physicians recommends monotherapy with cognitive therapy or second-generation antidepressant for patients in acute phase of moderate-to-severe depression
In this review, authors focused on the psychiatric issues that often accompany migraine and the effects of botulinum toxin A on migraine.
Investigators from the Veteran’s Affairs Center for Innovation to Implementation and Stanford University searched publication databases through June 2022 for observational studies about methamphetamine-associated heart failure.
However, expansion of telehealth yielded net increase in care for major depressive disorder, anxiety, and adjustment disorder
Deep learning, multidiagnostic model shows high accuracy before clinical examination
Investigators looked into which treatment fared better for patients with anxiety disorders: a mindfulness-based stress reduction intervention or escitalopram.
Being married, having a confidant associated with better mental health with COPD
Researchers measured associations between trauma and child psychiatric disorders in a birth cohort in Brazil.
Researchers assessed characteristics and correlates of metabolic syndrome in adolescents with major depressive disorder or bipolar disorder depression.
Danny Eckert, PhD, a researcher on human sleep and respiratory physiology, explains the potential bidirectional relationship and the clinical complications of COMISA, comorbid insomnia and sleep apnea.
A team of investigators evaluated the prevalence of noncancer-related pain conditions among adult individuals with attention-deficit/hyperactivity disorder.
As people living with HIV begin to age, their risk of developing HIV-associated cognitive decline increases. A specific training program to help patients with HIV with speed of processing (SOP) may help stall those effects.
Investigators sought to determine if response to sympathetic nerve blocks may be predictive of response to ketamine infusion.
In a systematic review, researchers examined the efficacy of digital headache management interventions for patients with a primary headache disorder.
Individuals with gastroesophageal reflux disease have a higher prevalence of psychiatric disorders, which calls for a multidisciplinary approach to treatment.
Reduction in caregiver depressive symptoms may have positive impact on child asthma outcomes, partially mediated by child depressive symptom severity
What is the link between multiple sclerosis and depression, and how can you help patients with their mental health?
How does cannabis affect COPD? To determine this, researchers assessed the risk for acute exacerbations of COPD in those who used cannabis vs those who did not.
Researchers sought to assess the impact of early vs late initiation of natalizumab by looking at clinical and imaging information of patients with MS.
Researchers examined correlations between suicidal ideation and suicide attempt history in patients with treatment-resistant depression following ketamine infusion.
Researchers examined associations between polygenic risk scores and neuropsychiatric conditions using data from phenome-wide association studies.
Researchers sought to assess the impact of the COVID-19 pandemic on sleep in children with neurodevelopmental disorders and insomnia symptoms, and identify the factors that led to changes in sleep habits.
Thomas Gillingwater, PhD, discusses how critical it is to start SMA treatment early in infants before the onset of symptoms.
Screening for MDD recommended for teens aged 12 to 18 years; anxiety screening recommended for children aged 8 to 18 years
Researchers compared the white matter networks of patients with remitted major depressive disorder and remitted bipolar disorder to find disease-specific alterations.
Researchers evaluated the efficacy of dextromorphan-bupropion among patients with major depressive disorder and comorbid anxiety.
However, no corresponding increase seen in mental health treatment